Tryngolza

Active Ingredient(s): Olezarsen Sodium
FDA Approved: * December 19, 2024
Pharm Company: * IONIS PHARMS INC
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tryngolza 80 mg Subcutaneous Injection, Solution
NDC: 71860-101
Labeler:
Ionis Pharmaceuticals, Inc.